Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1

Status

Recruiting 5Not yet recruiting 3Completed 3Unknown 1Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Genitourinary 1

Conditions

Brain Neoplasms 2Prostatic Neoplasms 1

Interventions

Carboplatin 75Cisplatin 73Bevacizumab 64Radiotherapy 57Drug Therapy 56Capecitabine 56tislelizumab 54Oxaliplatin 54Gemcitabine 46toripalimab 45Paclitaxel 45Specimen Handling 43sintilimab 39pembrolizumab 39anlotinib 38Cyclophosphamide 33130-nm albumin-bound paclitaxel 32Magnetic Resonance Spectroscopy 27Injections 27camrelizumab 26Pemetrexed 26Surgical Procedures, Operative 25lenvatinib 23Docetaxel 23Biopsy 23apatinib 22Etoposide 22Immune Checkpoint Inhibitors 21S 1 (combination) 20Fluorouracil 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Not yet recruiting × Memantine × Clear all
NCT07248228 2026-04-08

Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)

Case Comprehensive Cancer Center

Phase 2 Not yet recruiting
90 enrolled
CNS

Brain Neoplasms

NCT07470606 2026-03-13

MemoryRT

The University of Texas Health Science Center at San Antonio

Phase 2 Not yet recruiting
108 enrolled
CNS

Brain Neoplasms

NCT07164794 2025-11-19

Memantine Hydrochloride in Prostate Cancer Patients

Zhongda Hospital

Phase 2 Not yet recruiting
15 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡